Physician profile
Robert Warren Jackson
NPI 1689471310
$862.52
in general payments reported to CMS, 2019-2025
11 companies · $863 in 2025
The $863 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $274.69 | 2025 | Skytrofa, Yorvipath |
| Novo Nordisk INC | $164.21 | 2025 | Sogroya |
| Tolmar, INC. | $102.67 | 2025 | Fensolvi |
| Soleno Therapeutics, INC. | $75.90 | 2025 | Vykat Xr |
| Kyowa Kirin, INC. | $55.87 | 2025 | |
| Pfizer INC. | $53.37 | 2025 | |
| Medtronic, INC. | $34.85 | 2025 | Minimed 780g |
| Surmodics, INC. | $30.17 | 2025 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Abbvie INC. | $28.07 | 2025 | |
| Sanofi-Aventis U.S. LLC | $24.11 | 2025 | |
| Tandem Diabetes Care, INC. | $18.61 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.